Ultragenyx Pharmaceutical Inc. Insider Trading for June 2019

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in Ultragenyx Pharmaceutical Inc. for June 2019.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	61.50	1,226	75,399	17,650	18.9 K to 17.7 K (-6.50 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	63.01	1,489	93,822	18,876	20.4 K to 18.9 K (-7.31 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.48	649	41,199	20,365	21 K to 20.4 K (-3.09 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	61.50	1,226	75,399	17,650	18.9 K to 17.7 K (-6.50 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	63.01	1,489	93,822	18,876	20.4 K to 18.9 K (-7.31 %)
Jun 24 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	63.48	649	41,199	20,365	21 K to 20.4 K (-3.09 %)
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Option Exercise	A	63.27	12,000	759,240	12,000
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	3,500	0	13,361	9.9 K to 13.4 K (+35.49 %)
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Option Exercise	A	63.27	12,000	759,240	12,000
Jun 21 2019	RARE	Ultragenyx Pharmac ...	Harris Erik	EVP & Chief Commerc ...	Grant	A	0.00	3,500	0	13,361	9.9 K to 13.4 K (+35.49 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	3,000	0	47,924	44.9 K to 47.9 K (+6.68 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SULIMAN SHEHNAAZ	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SULIMAN SHEHNAAZ	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
Jun 13 2019	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	3,000	0	14,750	11.8 K to 14.8 K (+25.53 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Grant	A	0.00	3,000	0	9,750	6.8 K to 9.8 K (+44.44 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Grant	A	0.00	3,000	0	7,875	4.9 K to 7.9 K (+61.54 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	54.93	1,327	72,892	467,479	468.8 K to 467.5 K (-0.28 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	54.93	346	19,006	90,241	90.6 K to 90.2 K (-0.38 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	54.93	260	14,282	38,353	38.6 K to 38.4 K (-0.67 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	54.93	260	14,282	22,145	22.4 K to 22.1 K (-1.16 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	54.93	346	19,006	67,246	67.6 K to 67.2 K (-0.51 %)